Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Blis Technologies Limited Proxy Solicitation & Information Statement 2025

Jul 22, 2025

66168_rns_2025-07-23_69f6bcf9-5d77-4770-82eb-cb90c40d0747.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

BLIS Technologies Limited 399 Moray Place, Dunedin, New Zealand, 9016 blis.co.nz [email protected]

==> picture [86 x 52] intentionally omitted <==

23 July 2025

Notice of Meeting and proxy form

Notice is hereby given that the 2025 Annual Shareholder Meeting of BLIS Technologies Limited will be held on Thursday 21 August 2025 at 11.00am at Tūhura Otago Museum, The Hutton Theatre, 419 Great King Street, Dunedin and online at www.virtualmeeting.co.nz/blt25 (registrations will open at 10.30am).

Attached are the following documents which are being sent to shareholders today:

  • Notice of Meeting

  • Voting/Proxy Form

Ends

For further information, please contact:

Richard Wingham Chief Financial Officer Blis Technologies Limited +64 21 284 0446

About BLIS Technologies Ltd

Delivering proven health benefits through evidence-based, advanced probiotics.

BLIS Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS[®] products are sold throughout New Zealand and in Asia, Europe and the USA. More information about BLIS Technologies Ltd can be found at www.blis.co.nz.

Website: www.blis.co.nz Instagram: @blisprobiotics #blisk12 #blism18 #blisq24 Facebook: @BLISProbiotics